NEUROONE MEDICAL TECHNOLOGIES (NMTC) stock: insider trades, news & valuation
Health Care · Net buyingShare price and insider trades
NEUROONE MEDICAL TECHNOLOGIES insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $737K and 1 sold $55K of NMTC stock on the open market.
Get emailed when insiders cluster-buy stocks like NMTC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
NMTC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $67K | 1 | — | 0 |
| Q2 2026 | — | 0 | $32K | 1 |
| Q1 2026 | $670K | 1 | $23K | 5 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 NEUROONE MEDICAL TECHNOLOGIES Corp insider reported open-market purchases totaling $737K, while 1 insider reported sales totaling $55K. 0 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
NMTC stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 8SEC | David J. WambekeChief Business Officer | Buy | 33,333199,999 held (+20%) | $2.01 | $67K | -44.3% | — |
| Jul 2SEC | Mark ChristiansonMarket Development Director | Sell | 10,00020,692 held (−33%) | $3.18 | $32K | -64.8% | — |
| Apr 1SEC | Mark ChristiansonBusiness Development Director | Sell | 15,363198,920 held (−7%) | $0.74 | $11K | +51.4% | — |
| Mar 16SEC | Mark ChristiansonBusiness Development Director | Sell | 817214,383 held (−0%) | $0.80 | $654 | +40.0% | — |
| Mar 16SEC | Mark ChristiansonBusiness Development Director | Sell | 100214,283 held (−0%) | $0.80 | $80 | +40.0% | — |
| Mar 12SEC | Mark ChristiansonBusiness Development Director | Sell | 11,611217,309 held (−5%) | $0.80 | $9K | +40.0% | — |
| Mar 12SEC | Mark ChristiansonBusiness Development Director | Sell | 2,109215,200 held (−1%) | $0.80 | $2K | +40.0% | — |
| Mar 3SEC | David J. WambekeChief Business Officer | Buy | 1,000,000new position | $0.67 | $670K | +67.2% | — |
Insiders at NEUROONE MEDICAL TECHNOLOGIES Corp
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| David J. WambekeChief Business Officer | $737K | — | Sep 8, 2026 | — |
| Mark ChristiansonMarket Development Director | — | $55K | Jul 2, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
NMTC stock: common questions
Are NEUROONE MEDICAL TECHNOLOGIES Corp insiders buying NMTC stock?
In the past 12 months, 1 insiders reported open-market purchases of NMTC worth $737K. The latest was Chief Business Officer David J. Wambeke bought $67K of NMTC at $2.01.
Are NEUROONE MEDICAL TECHNOLOGIES Corp insiders selling NMTC stock?
1 insiders reported sales worth $55K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is NMTC's 52-week range?
Over the past year NMTC has traded between $0.98 and $6.18. It last closed at $1.12 on Oct 9, 2026.